TG Therapeutics, Inc. (TGTX)
27.96
+1.02
(+3.79%)
USD |
NASDAQ |
Mar 13, 16:00
27.98
+0.02
(+0.05%)
After-Hours: 20:00
TG Therapeutics Total Liabilities (Quarterly) : 415.23M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Precision BioSciences, Inc. | 62.17M |
| Amicus Therapeutics, Inc. | 675.63M |
| Geron Corp. | 345.21M |
| MannKind Corp. | 843.20M |
| Arcus Biosciences, Inc. | 933.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.063B |
| Shareholders Equity (Quarterly) | 648.02M |
| Debt to Equity Ratio | 0.3915 |
| Current Ratio | 4.102 |
| Net Debt Paydown Yield | 0.00% |